In Situ Hybridization Market - Top Companies and Manufacturers

Companies Dominating the In Situ Hybridization Landscape

Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Abbott
PerkinElmer, Inc.
Leica Biosystems Nussloch GmbH
F. Hoffman-La Roche Limited
NeoGenomics Laboratories, Inc.
Advanced Cell Diagnostics, Inc.
BioView
Agilent Technologies, Inc.
Merck KGaA
Bio-Rad Laboratories, Inc.
Oxford Gene Technology IP Limited
Bio-Techne Corporation

Browse Key Market Insights with Data Illustration:

In Situ Hybridization Market Size & Share, Growth Trends 2037

In the News

Bio-Techne Corporation launched new DNAscope Assays and expanded the RNAscope technology which is an advanced in situ hybridization (ISH) assay to allow for the quick and versatile creation of probes for any DNA target, as well as the visualization of targets in formalin-fixed paraffin-embedded (FFPE) tissues. Furthermore, DNAscope offers advantages over current commercial FISH methods and permits scientists to see and count gene copy number changes and gene rearrangements/fusions in tissues with spatial and morphological contexts.
Leica Biosystems Nussloch GmbH together with Bio-Techne introduced the CE-IVD marked RNAscope In Situ Hybridization Detection Kit to assist pathologists in gaining access to the top software to help their diagnostics labs and allow greater target sensitivity and specificity compared to conventional ISH techniques.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of in situ hybridization is assessed at USD 1.99 billion.

The in situ hybridization market size was over USD 1.82 billion in 2024 and is poised to reach USD 7.76 billion by the end of 2037, witnessing around 11.8% CAGR during the forecast period i.e., between 2025-2037. The rising incidence of cancer across the globe and the growing technological advancements in In-vitro diagnostics (IVD) will drive the market growth.

North America industry is poised to account for largest revenue share 45% by 2037, impelled by increasing spending in healthcare in the region.

The major players in the market are Thermo Fisher Scientific Inc., Abbott, PerkinElmer, Inc., Leica Biosystems Nussloch GmbH, F. Hoffman-La Roche Limited, NeoGenomics Laboratories, Inc., Advanced Cell Diagnostics, Inc., BioView, Agilent Technologies, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Oxford Gene Technology IP Limited, and others.

In Situ Hybridization Market - Top Companies and Manufacturers

Companies Dominating the In Situ Hybridization Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the in situ hybridization market worth?

Why is the demand for in situ hybridization growing?

Which region dominated the majority of in situ hybridization industry share?

Who are the top in situ hybridization companies?